Capsular polysaccharides as human vaccines.
D000328:Adult; D000917:Antibody Formation; D001419:Bacteria / Q000472:pathogenicity; D001424:Bacterial Infections / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology*; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D002675:Child, Preschool; D003170:Complement Pathway, Alternative; D003165:Complement System Proteins / Q000276:immunology; D000939:Epitopes; D005260:Female; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007231:Infant, Newborn; D008968:Molecular Conformation; D009345:Neisseria meningitidis / Q000276:immunology; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial / Q000276:immunology*; D011247:Pregnancy; D013292:Streptococcus agalactiae / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology
D001428:Bacterial Vaccines; D000939:Epitopes; D011135:Polysaccharides, Bacterial; D003165:Complement System Proteins